BWXT
VENTE TOTALE: 10 000 titres (~1 712 147,00 $ US)
- Insiders
- Geveden Rex D
- Total bought
- —
- Total sold
- $1,712,147
- Last activity
- 2026-08-12
- Last synced
-
2026-08-21 23:36:53
Insider holdings as a share of total assets aren't available for this company.
Price (1 year)
Live chart from TradingView - pulls its own market data, independent of this site's database. Symbol resolution is best-effort (defaults to NASDAQ) since we don't store the exchange prefix.
Market snapshot
Signal
Neutral signal Scored 2026-09-06
BWXT benefits from a credible congressional trade signal backed by ~$129k in 2026 purchases and strong thematic tailwinds (nuclear services, AI-driven energy demand), but the catalyst confidence of 0.68 is tempered by a…
The first sentence of the analysis written for BWXT on 2026-09-06 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 22.9% | 24.2% | 24.9% | 24.7% | 25.9% | |
| Ebit Margin | 13.8% | 14.4% | 14.8% | 15.7% | 20.3% | |
| Ebitda Margin | 17.2% | 17.5% | 17.9% | 19.0% | 23.6% | |
| Operating Profit Margin | 10.1% | 14.1% | 15.3% | 15.6% | 16.3% | |
| Pretax Profit Margin | 12.4% | 12.9% | 12.9% | 14.1% | 18.6% | |
| Continuous Operations Profit Margin | 10.3% | 10.4% | 9.9% | 10.7% | 14.4% | |
| Net Profit Margin | 10.3% | 10.4% | 9.8% | 10.7% | 14.4% | |
| Bottom Line Profit Margin | 10.3% | 10.4% | 9.8% | 10.7% | 14.4% | |
| Current Ratio | 2.322 | 1.961 | 2.181 | 2.098 | 1.683 | |
| Quick Ratio | 2.253 | 1.876 | 2.107 | 2.090 | 1.677 | |
| Solvency Ratio | 0.144 | 0.206 | 0.179 | 0.167 | 0.201 | |
| Cash Ratio | 0.748 | 0.156 | 0.210 | 0.096 | 0.074 | |
| Price To Earnings Ratio | 48.011 | 36.166 | 28.631 | 22.338 | 14.778 | |
| Price To Earnings Growth Ratio | 2.844 | 2.423 | 9.305 | -1.131 | 1.348 | |
| Forward Price To Earnings Growth Ratio | 2.844 | 2.423 | 9.305 | -1.131 | 1.348 | |
| Price To Earnings Diluted Ratio | 48.145 | 36.283 | 28.631 | 22.338 | 14.778 | |
| Price To Earnings Diluted Growth Ratio | 2.842 | 2.493 | 9.305 | -1.131 | 1.303 | |
| Price To Book Ratio | 12.835 | 9.439 | 7.532 | 7.098 | 7.085 | |
| Price To Sales Ratio | 4.948 | 3.773 | 2.816 | 2.379 | 2.125 | |
| Price To Free Cash Flow Ratio | 53.596 | 40.036 | 33.095 | 114.486 | 60.209 | |
| Price To Operating Cash Flow Ratio | 32.982 | 24.975 | 19.329 | 21.705 | 11.694 | |
| Debt To Assets Ratio | 0.472 | 0.368 | 0.440 | 0.492 | 0.475 | |
| Debt To Equity Ratio | 1.635 | 0.977 | 1.296 | 1.722 | 1.867 | |
| Debt To Capital Ratio | 0.620 | 0.494 | 0.564 | 0.633 | 0.651 | |
| Long Term Debt To Capital Ratio | 0.620 | 0.491 | 0.563 | 0.632 | 0.651 | |
| Financial Leverage Ratio | 3.464 | 2.656 | 2.943 | 3.500 | 3.926 | |
| Working Capital Turnover Ratio | 4.759 | 6.018 | 5.898 | 6.221 | 7.613 | |
| Operating Cash Flow Ratio | 0.714 | 0.861 | 0.970 | 0.665 | 0.840 | |
| Operating Cash Flow Sales Ratio | 0.150 | 0.151 | 0.146 | 0.110 | 0.182 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.615 | 0.624 | 0.584 | 0.190 | 0.194 | |
| Debt Service Coverage Ratio | 9.117 | 7.843 | 6.980 | 8.178 | 11.497 | |
| Interest Coverage Ratio | 7.312 | 9.642 | 8.144 | 9.573 | 9.672 | |
| Short Term Operating Cash Flow Coverage Ratio | 54.528 | 32.674 | 58.192 | 39.153 | 0.000 | |
| Operating Cash Flow Coverage Ratio | 0.238 | 0.387 | 0.301 | 0.190 | 0.325 | |
| Capital Expenditure Coverage Ratio | 2.600 | 2.658 | 2.404 | 1.234 | 1.241 | |
| Dividend Paid And Capex Coverage Ratio | 1.732 | 1.688 | 1.539 | 0.876 | 0.988 | |
| Dividend Payout Ratio | 0.280 | 0.313 | 0.346 | 0.340 | 0.260 | |
| Enterprise Value Multiple | 31.440 | 23.587 | 18.257 | 15.460 | 11.326 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 22.9% | ▼-1.4% | ▼-1.7% |
| Ebit Margin | 13.8% | ▼-0.5% | ▼-2.0% |
| Ebitda Margin | 17.2% | ▼-0.3% | ▼-1.8% |
| Operating Profit Margin | 10.1% | ▼-4.0% | ▼-4.2% |
| Pretax Profit Margin | 12.4% | ▼-0.4% | ▼-1.7% |
| Continuous Operations Profit Margin | 10.3% | ▼-0.1% | ▼-0.8% |
| Net Profit Margin | 10.3% | ▼-0.1% | ▼-0.8% |
| Bottom Line Profit Margin | 10.3% | ▼-0.1% | ▼-0.8% |
| Current Ratio | 2.322 | ▲0.361 | ▲0.273 |
| Quick Ratio | 2.253 | ▲0.376 | ▲0.252 |
| Solvency Ratio | 0.144 | ▼-0.061 | ▼-0.035 |
| Cash Ratio | 0.748 | ▲0.592 | ▲0.491 |
| Price To Earnings Ratio | 48.011 | ▲11.845 | ▲18.026 |
| Price To Earnings Growth Ratio | 2.844 | ▲0.421 | ▼-0.114 |
| Forward Price To Earnings Growth Ratio | 2.844 | ▲0.421 | ▼-0.114 |
| Price To Earnings Diluted Ratio | 48.145 | ▲11.861 | ▲18.110 |
| Price To Earnings Diluted Growth Ratio | 2.842 | ▲0.349 | ▼-0.120 |
| Price To Book Ratio | 12.835 | ▲3.397 | ▲4.038 |
| Price To Sales Ratio | 4.948 | ▲1.175 | ▲1.740 |
| Price To Free Cash Flow Ratio | 53.596 | ▲13.560 | ▼-6.689 |
| Price To Operating Cash Flow Ratio | 32.982 | ▲8.007 | ▲10.845 |
| Debt To Assets Ratio | 0.472 | ▲0.104 | ▲0.022 |
| Debt To Equity Ratio | 1.635 | ▲0.658 | ▲0.136 |
| Debt To Capital Ratio | 0.621 | ▲0.126 | ▲0.028 |
| Long Term Debt To Capital Ratio | 0.621 | ▲0.129 | ▲0.029 |
| Financial Leverage Ratio | 3.464 | ▲0.809 | ▲0.167 |
| Working Capital Turnover Ratio | 4.759 | ▼-1.259 | ▼-1.343 |
| Operating Cash Flow Ratio | 0.714 | ▼-0.147 | ▼-0.096 |
| Operating Cash Flow Sales Ratio | 0.150 | ▼-0.001 | ▲0.002 |
| Free Cash Flow Operating Cash Flow Ratio | 0.615 | ▼-0.008 | ▲0.174 |
| Debt Service Coverage Ratio | 9.117 | ▲1.274 | ▲0.394 |
| Interest Coverage Ratio | 7.312 | ▼-2.330 | ▼-1.557 |
| Short Term Operating Cash Flow Coverage Ratio | 54.528 | ▲21.854 | ▲17.619 |
| Operating Cash Flow Coverage Ratio | 0.238 | ▼-0.149 | ▼-0.050 |
| Capital Expenditure Coverage Ratio | 2.600 | ▼-0.058 | ▲0.573 |
| Dividend Paid And Capex Coverage Ratio | 1.732 | ▲0.044 | ▲0.367 |
| Dividend Payout Ratio | 0.280 | ▼-0.033 | ▼-0.028 |
| Enterprise Value Multiple | 31.440 | ▲7.853 | ▲11.426 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $15.83B | $10.20B | $7.03B | $5.31B | $4.51B | |
| Enterprise value | $17.34B | $11.18B | $8.16B | $6.56B | $5.67B | |
| EV / Sales | 5.42x | 4.14x | 3.27x | 2.94x | 2.67x | |
| EV / Op. cash flow | 36.13x | 27.38x | 22.44x | 26.83x | 14.69x | |
| EV / Free cash flow | 58.72x | 43.89x | 38.42x | 141.51x | 75.62x | |
| EV / EBITDA | 31.44x | 23.59x | 18.26x | 15.46x | 11.33x | |
| Net debt / EBITDA | 2.74x | 2.07x | 2.53x | 2.95x | 2.31x | |
| Current ratio | 2.32x | 1.96x | 2.18x | 2.10x | 1.68x | |
| Income quality | 1.46x | 1.45x | 1.48x | 1.02x | 1.26x | |
| Graham number | $33 | $29 | $25 | $22 | $22 | |
| Graham net-net | -$20 | -$12 | -$13 | -$14 | -$14 | |
| Tax burden | 82.9% | 80.9% | 76.5% | 75.8% | 77.3% | |
| Interest burden | 90.0% | 89.8% | 87.2% | 89.6% | 91.7% | |
| Working capital | $888.3M | $455.8M | $442.8M | $403.8M | $314.1M | |
| Invested capital | $3.30B | $2.19B | $2.15B | $2.03B | $1.83B | |
| Return on assets | 7.7% | 9.8% | 8.9% | 9.1% | 12.2% | |
| Operating ROA | 9.1% | 13.6% | 14.3% | 13.6% | 14.4% | |
| Return on tangible assets | 9.6% | 11.7% | 10.9% | 11.2% | 15.1% | |
| Return on equity | 26.8% | 26.1% | 26.3% | 31.8% | 48.0% | |
| Return on invested capital | 7.4% | 12.8% | 12.3% | 11.7% | 13.1% | |
| Return on capital employed | 9.0% | 15.9% | 16.1% | 15.5% | 16.9% | |
| Earnings yield | 2.1% | 2.8% | 3.5% | 4.5% | 6.8% | |
| Free cash flow yield | 1.9% | 2.5% | 3.0% | 0.9% | 1.7% | |
| Capex / Op. cash flow | 38.5% | 37.6% | 41.6% | 81.0% | 80.6% | |
| Capex / Depreciation | 169.0% | 178.9% | 192.6% | 268.6% | 450.3% | |
| Capex / Sales | 5.8% | 5.7% | 6.1% | 8.9% | 14.6% | |
| SG&A / Sales | 12.3% | 11.8% | 11.2% | 10.5% | 10.8% | |
| R&D / Sales | 0.4% | 0.3% | 0.3% | 0.4% | 0.5% | |
| Stock comp / Sales | 0.8% | 0.8% | 0.6% | 0.6% | 0.9% | |
| Intangibles / Total assets | 19.4% | 15.8% | 17.6% | 18.6% | 18.8% | |
| Days sales outstanding | 108d | 103d | 99d | 110d | 118d | |
| Days payables outstanding | 21d | 28d | 25d | 28d | 44d | |
| Operating cycle | 115d | 110d | 104d | 111d | 118d | |
| Cash conversion cycle | 94d | 82d | 79d | 83d | 74d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Valuation
Market cap ▲+55.2%EV / Sales ▲+31.1%EV / EBITDA ▲+33.3%EV / Op. cash flow ▲+8.758Earnings yield ▼-0.007Graham number ▲+4.445
Profitability
Return on equity ▲+0.007Return on assets ▼-0.021Return on invested capital ▼-0.054Return on capital employed ▼-0.069Operating ROA ▼-0.045Income quality ▲+0.008Tax burden ▲+0.020
Efficiency
Days sales outstanding ▲+4.723Days payables outstanding ▼-7.261Operating cycle ▲+4.428Cash conversion cycle ▲+11.690Capex / Sales ▲+0.001R&D / Sales ▲+0.002
Balance-sheet strength
Current ratio ▲+0.361Net debt / EBITDA ▲+0.673Working capital ▲+432541000.000Invested capital ▲+1117548000.000Intangibles / Total assets ▲+0.037
Change over 5 years
Valuation
Market cap ▲+250.6%EV / Sales ▲+103.1%EV / EBITDA ▲+177.6%EV / Op. cash flow ▲+21.448Earnings yield ▼-0.047Graham number ▲+10.826
Profitability
Return on equity ▼-0.213Return on assets ▼-0.045Return on invested capital ▼-0.057Return on capital employed ▼-0.080Operating ROA ▼-0.054Income quality ▲+0.194Tax burden ▲+0.056
Efficiency
Days sales outstanding ▼-9.954Days payables outstanding ▼-23.123Operating cycle ▼-3.740Cash conversion cycle ▲+19.384Capex / Sales ▼-0.089R&D / Sales ▼-0.001
Balance-sheet strength
Current ratio ▲+0.638Net debt / EBITDA ▲+0.435Working capital ▲+574220000.000Invested capital ▲+1473382000.000Intangibles / Total assets ▲+0.006
Employee count
Peer market caps
Congressional trades
Recent trades
| Date | Representative | Type | Amount |
|---|---|---|---|
| 2026-07-30 | April Delaney | Purchase | $1,001 - $15,000 |
| 2026-07-27 | April Delaney | Purchase | $1,001 - $15,000 |
| 2026-07-24 | April Delaney | Purchase | $15,001 - $50,000 |
| 2026-05-15 | April Delaney | Purchase | $15,001 - $50,000 |
| 2026-05-14 | April Delaney | Purchase | $1,001 - $15,000 |
| 2026-05-08 | April Delaney | Purchase | $15,001 - $50,000 |
| 2026-05-07 | April Delaney | Purchase | $1,001 - $15,000 |
| 2025-06-11 | Lisa McClain | Purchase | $1,001 - $15,000 |
| 2023-09-08 | Lois Frankel | Sale | $1,001 - $15,000 |
| 2023-06-28 | Lois Frankel | Sale (Partial) | $1,001 - $15,000 |
| 2022-01-10 | Lois Frankel | Sale (Partial) | $1,001 - $15,000 |
| 2021-12-10 | Lois Frankel | Purchase | $1,001 - $15,000 |
| 2018-11-14 | Lamar Smith | Purchase | $1,001 - $15,000 |
| 2018-08-16 | Lamar Smith | Purchase | $1,001 - $15,000 |
Recent news
- 2026-08-17 Can BWXT''s Nuclear Cleanup Services Add a New Growth Avenue? BWX Technologies expands its nuclear services portfolio through decommissioning, remediation, waste management and nuclear site support.
- 2026-08-17 3 Nuclear Stocks With Real Revenue vs. 3 That Are Still Pre-Revenue. Here''s Where the Money Actually Is. Nuclear is booming, and the smartest money may be flowing to the companies already selling the power, equipment, and fuel.
- 2026-08-14 Dividend Champion, Contender, And Challenger Highlights: Week August 16 A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.
- 2026-08-13 Can BWX Technologies'' Nuclear Medicine Expansion Boost Growth? BWXT expands its commercial nuclear portfolio through nuclear medicine, isotope production and radiopharmaceutical capabilities.
- 2026-08-11 BWX Technologies: Fundamentals Are Good But Valuation Is Expensive BWX Technologies (BWXT) earns a hold rating due to strong fundamentals but limited upside at current valuation. Naval business provides multi-year revenue visibility, supported by a $6.93 billion Government Operations backlog. Commercial Operations offers growth potential, with 39% organic revenue growth in Q1 2026 and margin expansion opportunities.
- 2026-08-10 Unlocking $50 Billion Across the Nuclear Value Chain The Department of Energy (DOE) has narrowed the competition for its proposed Nuclear Lifecycle Innovation Campuses (NLICs) to five states: Utah, Tennessee, Oklahoma, Louisiana, and Idaho. The selection advances an effort that could create new investment and contracting opportunities across nearly every part of the nuclear value chain.
- 2026-08-07 Advance Auto Parts vs. BWX Technologies: Is an Auto Parts Retailer or a Nuclear Energy Pioneer the Better Buy in 2026? Advance Auto Parts is executing a major restructuring plan to streamline its supply chain and enhance store efficiency. BWX Technologies maintains a dominant position in the nuclear propulsion market with a massive revenue backlog from government contracts.
- 2026-08-07 3 Nuclear Energy Stocks Powering the AI Boom in August Artificial intelligence has an electricity problem, and nuclear is the answer investors keep circling back to.
- 2026-08-04 BWXT Q2 Earnings Call Centers on Higher Outlook and Nuclear Focus BWXT raises its 2026 outlook as stronger operations support higher guidance, while a medical divestiture and PCG deal sharpen its nuclear focus.
- 2026-08-04 Got $5,000? The Smartest Way to Invest in the Nuclear Boom. BWX Technologies is one of the most well-rounded plays in the nuclear market.